Back to Search
Start Over
P-111 PERSPECTIVE: Tepotinib plus cetuximab in patients with RAS/BRAF wild-type left-sided metastatic colorectal cancer and acquired resistance to anti-EGFR antibody therapy due to MET amplification.
- Source :
-
Annals of Oncology . 2021 Supplement 3, Vol. 32, pS136-S137. 2p. - Publication Year :
- 2021
- Subjects :
- *CETUXIMAB
*COLORECTAL cancer
*EPIDERMAL growth factor receptors
Subjects
Details
- Language :
- English
- ISSN :
- 09237534
- Volume :
- 32
- Database :
- Academic Search Index
- Journal :
- Annals of Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 152686705
- Full Text :
- https://doi.org/10.1016/j.annonc.2021.05.166